VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,846,000 | -31.7% | 286,570 | -4.4% | 3.28% | -20.3% |
| Q1 2022 | $11,492,000 | +66.9% | 299,670 | +39.4% | 4.11% | +70.8% |
| Q4 2021 | $6,885,000 | +10.2% | 214,970 | +1.4% | 2.41% | -4.8% |
| Q3 2021 | $6,250,000 | +11.1% | 212,070 | +28.1% | 2.53% | +9.9% |
| Q2 2021 | $5,626,000 | +7.0% | 165,570 | +2.3% | 2.30% | -2.1% |
| Q1 2021 | $5,258,000 | -6.7% | 161,772 | +3.4% | 2.35% | -11.6% |
| Q4 2020 | $5,637,000 | +4.8% | 156,417 | +13.9% | 2.66% | -11.6% |
| Q3 2020 | $5,379,000 | +6.8% | 137,362 | 0.0% | 3.01% | +0.1% |
| Q2 2020 | $5,038,000 | +31.9% | 137,362 | -17.2% | 3.01% | +12.2% |
| Q1 2020 | $3,820,000 | +18.4% | 165,797 | +50.4% | 2.68% | +48.9% |
| Q4 2019 | $3,227,000 | +12.9% | 110,217 | +3.0% | 1.80% | +2.7% |
| Q3 2019 | $2,858,000 | +12.0% | 107,017 | +7.2% | 1.75% | +10.5% |
| Q2 2019 | $2,551,000 | – | 99,817 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |